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In the preparation of this paper I read more than one 
hundred and twenty five articles on hypertension and hypoten-
sive chemical substances. Although much has been written on 
drugs like veratrum viride and tetraethyl ammoni~w chloride, 
very little has been done with substances as dibenamine, plas-
mochin, penthamethonium iodide, and others. 
The introduction includes a short review of the different 
types of hypertension, including a discussion of the most im-
portant factors which may affect or be involved in the disease. 
The most significant types of treatment currently in use are 
discussed. The need for drug therapy is emphasized. 
I have classified the hypotensive drugs into sympatholy-
tic, ganglionic blocking, and drugs acting peripherally. This 
classification is based on the most characteristic mode of ac-
tion, depending upon the concentration. I have discussed the 
physiological effects and the hypotensive action of each of the 
most important drugs in use at present. 
A. VARIOUS TYPES OF IfYPERTENSION 
More than 625,000 Americans die every year from different 
types of circulatory disease. The death rate exceeds that of 
all other diseases in the United States. It is three times as 
high as the cancer mortality rate; six times higher than that 
of accidents; ten times higher than pneumonia; and thirteen 
times as high as tuberculosis. Ninety percent or all the cir-
culatory diseases are due to arteriosclerosis, rheumatic heart 
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disease, and hypertension. Statisticians estimate that about 
15,000,000 of our population are sufrering from hypertension 
today; that about halr of the population over fifty years or 
age v1ill suffer and probably die of hypertension or its compli-
cations. 
High death incidence due to circulatory diseases is not 
confined to the United States alone, since a similar condition 
exists in other countries. Alstad (1950) reported that in Ne~r 
Zealand circulatory diseases are the greatest single cause or 
death and account ror more than 40 percent of the total deaths. 
As these figures sh0\'1, there is a high incidence of the 
disease ~~d a high mortality rate. Thus, it is very important 
to U..'Yl.derstand what is mea.nt by hypertension. But first it is 
necessary to know what is meant by normal blood pressure. 
Blood pressure is the lateral force exerted on the -vralls of the 
blood vessels by the blood they contain. It is dependent on 
the viscocity of the blood, blood volume, cardiac output, and 
peripheral resistance. In the normal individual the blood vo-
lume and viscocity are kept constant since they are controlled 
by the interchange of fluid between the tissue spaces and plas-
ma, secretion of urine, and the function of the spleen. Under 
normal conditions the adjus tments of blood pressure depend upon 
the cardiac output and the state of the peripheral arteriolar 
bed. 
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Wnere is the demarcation between normal and high blood 
pressure? The interpretation of the term high blood pressure 
varies with different standards and different investigators, 
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since the r ange of varia tion i s i n flu e..n.ced by ex ternal and 
in tern a.l environments. 
The value of normal blood pressure has been reduced in 
the Onited States Army from 1 20 nm . of mercury a s systolic 
over 90 mm. of mercury as diastolic to 110 over 70. fhe United 
Sta tes Navy has set the normal systolic standard at 105 ID.m. of 
mercury. As in most medical journals and textbooks the readings 
of 120 systolic and 80 diastolic are used, these values vvill be 
considered as normal for the purpose of this paper. 
In 1947 fhreefoot reported a study made on 31,000 women 
and 43,000 men (mostly university students) in which he observ-
ed that 2. 36 percent of the men and 15.98 percent of the women 
had systolic blood pres sures below 100 and that 30.22 percent 
of the men and 11.09 percent of the v~omen had pressures between 
100 and 109. If the maximum limits of normal blood pressures 
are lEO systolic and 80 di a stolic, half of the women aild one 
third of the men would h ave to b e considered hypertensive. 
However, blood pressure may vary above or below the a ccepted 
standards without b eing called abnormal, a s in such conditions 
of shock, pain..;. fright, and anger. Hypertension exists when 
arterial blood pressure is greater than 160 mm. of mercury and 
the diastolic pressure above 80 mm. of mercury. 
Hypertensive condition:s have been classified by Herdon 
(194'6) and Page (1939) as follows: Essential, Renal, and 
Symp tom a tic. 
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1. Symptomatic hypertension 
Symptomatic hypertension is a broad ca tegory that in-
cludes psychological high blood pressure due to pain and emo-
tional disturbances, cerebral hypertension due to intracraneal 
pressure, cardiova scular due to heart block, heart failure and 
arteriosclerosis, and endocrinal hypertension due to abnormal 
functioning of the pituitary and the adrenal glands. 
We are living in the so-called norma.l modern world where 
our activities, stresses, and strains in daily actions serve 
a.s s timuli producing and maintaining an increa sed ntonus" in 
our physiological system. If our body, which is accustomed t 0 
such stimulation, finds these absent, the blood pressure de-
creases. fhis response is transi ent for average people, but 
if chronic worrying, fear or e:xcessi ve emotional e:xci tement 
makes this condition pel~anent, then the average normal pres-
sure becomes abnorma.l. 
~. Renal hypertension 
It has been kno~n for many yea r s thGt the most common 
type of human hypertension wa s that in whi ch the kidneys did 
not function properly, resulting in high blood pressure. Work-
ing on the assumption tha t the hyp er t en sion was of renal origi~ 
. Goldblatt. (19 34) found t hat he could induce hypertension in 
dogs by constricting or occluding the main renal arteries. 
La.ter experiments produced similar results with sheep s, rabbits 
rats, goats, and monkeys. In 1938 Goldring, Chasis, Ranges, 
and Smith proved that the changes in the hemodynamics of the 
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kidney during hypertension (and the increase in systematic 
pressure) may be explained on the basis of a reduction of 
renal blood flow with the maintenance of pressure in the 
glomeruli. 
A humoral mechanism may account for the renal hyperten-
sion. Thus Page (1935), Goldblatt (1939), Blalock (1937), and 
Glenn (1938), demonstrated by transection of the nerves to the 
kidneys, that denervation did not prevent or abolish high bloo , 
pressure in experimental animals, ruling out the possibilities 
for a nervous reflex mechanism. In further experiments Gold-
blatt (1937) demonstrated that renal hypertension wa s of a 
chemical nature, since no rise in blood pressure occurred when 
both the renal arteries and renal veins were tied at the same 
time. Block (1937) and Glenn and Child (1907) reported a rise 
in blood pressure on transplantation of kidneys to the neck 
region or to the groin, with all nervous connections to the 
body eliminated and with the renE~ arteries occluded. Fasciol 
and coworkers (1938) and Page (1940) demonstrated that the 
blood taken from a kidney, with renal arteries constricted, c:m 
used to perfuse a normal animal, has active vasoconstrictor an 
pressor characteristics. :Ihis substance is said to be libera-
ted by the kidneys and is presumed to be a proteolytic enzyme 
of a pseudoglobulin nature (Helmer and Page 1939). It is not 
a pressor in itself, but reacts with another substance in bloo 
plasma, which seems to be formed in the liver, since liver ex-
tractions decrease the amount of this substruLce in the blood. 
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fhis chemical substance has been called hypertensinog en by 
Braun-Menendez and his coworkers in Argentina. In the United 
States it has been called preangiotonin. :I'he reaction forms 
angiotonin, which has been found in grea t amounts in animals 
with hypertension (Page 1941). .Angiotonin has pressor charac-
teristics and is destroyed by another substance called angio-
tonase, also knovm as hypertensinase in Argentina (Fasciola, 
Lelovi, Munoz, and Braun-Menendez 1940); (Friedman 1941); (Dex 
ter and Braun-Menendez 1941). A rena l change or hemodynamic 
disturbance decreases the blood flow, damages the tubular appa -
atus, and releases renin into the blood stream. l'hi.s in turn 
activates the plasma globulin producing angiotonin, which is 
vasoconstrictor and increases the blood pressure. Onder norma 
conditions there is either an absence of renin or a balance be 
tween renin formation and renin destruction. lin alternate hy-
pothesis pres:en ted by Bing and Zuker (1941) assumes that an 
amine is released by the ischemic kidneys which interferes wit 
enzymatic action when there is no oxygen present, but produces 
inert products in the presence of oxygen. 
3. Essential hypertension 
Essential hypertension is the most common type of high 
blood pre s sure and the type which may be treated with sympa tho-
lytic substances. By essential hypertension is meant a high 
blood pressure without apparent organic cause. It is said to 
be diagnosed mainly by ruling out all other types of high bloo 
pressure. The cause is not knovm. 
It has been the opinion of the public tha t the disease is 
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one o f middle or old age , when it usually assumes its climax 
but it is clear tha t the process begins earli er. fhere are 
different degrees of hypsr tension, cla ssified , according to 
advancing symptom s , as mild, modera te, and severe. In mild 
cases an increase in blood pressure is accompani ed by an equal 
increase in the heartbea t and the flow has a tendency to remai 
normal although the heart has to do heavier v;ork . In advanced 
cases distressing symp toms are present, such as headaches , fa-
tigue, irritability, n ausea, vomiting, vertigo, insomni a , and 
wealmess. Iherapy is necessary. 
B. Factors Involved in Hypertension 
The high blood pressure may be . due to increase in cardia 
output, increase in blood volume , blood viscocity, and per i -
pheral resistance. In essenti al hypertHlsion the putput of th 
heart , the blood flow, and the vi scoci ty of the blood rE:mc:,in 
cons tant ( Austrian 1911; Burwell anci Smith 1929), thus the 
elevated blood pressure must be due to increased peripheral re 
sist&nce (Goldring and Chasis 1944) . This increased peripher 
al resistance, in turn, can be accomplished in three ways: 
narrowing of the vessels themselves, overactivity of vasomotor 
nerves, and hypertonus of the blood vessels (Herdon 1946) . 
Additional fac to.rs which may affect the blood pressure 
in one way or ano ther are environment , r a ce, age , heredity, 
diet, and exercise. Ihe influence of the environment is sho l"m 
by the correla tion be t v,-een hypertension and stress of living. 
Foster (19 f:7), Dennison (19 ~9), and Weiss (19 38), found that 
among the orientals and native African negroes hyp ertension is 
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very rare. But if these races were cro ssed wi th American, the 
high blood pressure appeared in proportion with the increasing 
amount of American 11 blood 11 present. lhis suggests a racial 
resistance or racial susceptibility to the disease. 
Master, Mar k s, and Dack (1943), in their "Hyp erten sion i1 
People Over Forty", found tl'1a t hypertension occurs above this 
age in ninety percent of the cases , and tha t from this ag e on 
the incidence of the disease increased. I'hey found eel so that 
the most common hypertension at thirty yea rs of age or less wa 
nephritic hypertension. Andrus (1936) proposed that hyperten-
sion is due to senescence of blood vessels but experimental 
corroboration of this theory is lacking. 
I he reason for the prevalence of p.ypertension in the 
female rather than the male is not known. Blackford and co-
workers (1930) and Masters and coworkers (1943) suggest that 
t his may be due to the toxemia and inflammation of the kidneys 
common during pregnancy. Ihe toxemi c conditions occur more 
frequently in those subjects predisposed to hypertension, and 
in a high percentage of the cases high blood pressure due to 
to x emia persists permanently. 
fhe evidence for an inherited p redisposition to hyperten-
sion is very strong. bffor ts have been m&.de to apply lVlendeli an 
principles . Ayman (19 34), in an ex tensive study of 1524 members 
of 287 families, f ound tha t parents with no hypertension at all 
had children with an incidence of elevated blood pressure of 
3 .1 percent. In families where one of the parents had normal 
blood pressure and the other hi gh blood _Qressure. the children 
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had an incidence of 28.3 percent. If both parents were hyper-
tensi ves, the incidaJ.ce in their children was eleva. ted to 45.5 
percent. Hines (1940) found an incidence of 8 7 per'cen t in sub 
jects v.rith positive f&Iuily historie s and 30 perc ent in subject 
with normal families. Furthermore, Platt (1947) stated that 
if a patien t with hypertension has a positive family history, 
the chances are six to one that the hypertension is essen t ial. 
Although the high blood pressure itself' is not inherited, t he 
tendency to have the disease is inherited (Page 1949). 
A low sodium diet and a rice di e t have been used for man~ 
years as treatment of hypertension' but the evidence for its 
value is inconcl usive, and the mode of action of the protein-
free diet is not yet understood. Kohan-Kucharik (1945) made 
studies in the war famine produced in Budapest, where an en-
forced p rotein-free diet was observed, and after ten months of 
this diet hypertensive patients did not show any improvements 
in their symptoms. Schraeder (1945) prescribed a sodium chlo-
ride-free diet and noticed that it was ineffective in a large 
number of subjects. However the hypotensive effect in a small 
portion of the group suggested an al tera t i on of the normal 
functioning of the adrenal cortex. Experimental laboratory 
evidence for such a mechanism wa s not f ound in the litera ture 
read. 
Not all the experi ments have been negative, since Dick 
and Schwartz (1948) reported a reduction in blood pressure in 
ten out of eleven dogs maintained on a rice-and-juice diet. 
The general opinion is that positive results in experimental 
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animals and clinical cases have been due to psychotherapic fac-
tors or to nutritional imbalance of the body, since loss of 
vreight has been reported in experiments ;·1i th a low protein diet 
Obesity has been related to high blood pressure. Statis-
tics sho\~ that persons vrith a tendency to obesity are more.like-
ly to exhibit hypertension, but a causal relation betv1een both 
of them has not yet been demonstrated. 
An elevated blood pressure and an increased circulatory 
flow through the active organ answers the need to remove waste 
products and to supply both nutrient materials and oxygen in 
exercised muscles. This increased circulatory flow is accom-
plished by increasing the heart rate and by dilation of local 
blood vessels in the site of the exercise. The increased heart 
rate is due to the increased respiratory pump action of the 
lungs, increased milking effect of the muscles, and augmentatio 
of the venous return to the heart. This augmented venous re-
turn stimulates the Bainbridge reflex mechanisms which inhibits 
the cardioinhibitory center and increases the heart rate. The 
L11creased amount of carbon dioxide that is present in the blood 
as a. result of the exercise stimulates vasoconstrictor center 
in the medulla, increasing the tonus in the arteriolar bed and 
thereby increasing the peripheral resistance to the blood flow. 
While all these mechanisms are in effect, the lactic acid re-
sulting from the glycolysis of the carbohydrates at the site 
of the exercise serves as a local vasodilator, and together wit! 
the increased pressure brings more blood to the muscles in ac-
tion. 
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As already pointed out, u.~er normal conditions, all 
these factors increase the blood pressure in a limited way, 
while buffer mechanisms tend to maintain a normal blood flow. 
In abnormal conditions the elevated pressure may persist and 
side effects that are harmful to the organism can be noted. 
c. Incidence of the Disease and ~ .Q! Treatment 
So much of our population is suffering from hypertension 
e.nd so little is knmm about its origin or cure that efforts 
toward its relief are constantly beingconducted in labqratoria 
and research institutions. The treatment of hypertension must 
not only reduce the vasoconstriction and the high blood pres-
sure, maintaining an adequate blood supply to all the organs o 
the body at all times, but it must maintain the comfort and 
peace of mind of the patient. There are di'ff'erent \'fays in 
which essential hypertension may be relieved someivhat. If 
the blood pressure is not too high and there are no complicate 
symptoms, psychotherapy may be applied lvith benefit. If the 
blood pressure is somewhat higher, only two other 'flays are 
effective to a limited extent.: sympathectomy and drug therapy 
In sympathectomy the nerves that control the blood ves-
sels are cut and thus the pressure of the blood is lOi-Tered by 
reduction of the tonus of the arterioles (Wilkins 1946). Sym-
pathectomy is used as a last measure, when the symptoms are 
grave and no other fo.rm of therapy has been effective. This 
method consists of ganglionectomy of the lumbar region and ex-
cision, especie.lly, of the nei"Ves that control the splanchnic 
vessels (Smithwick 1940). The reduced blood pressure obtained 
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by tbis method is maintained for several years, at the end of 
which the pressure begins to rise again to preoperative levels 
(Eardley, Gladston, and Daydy 1943). fhe cause of post-opera 
tive elevation is not knov.n although it is believed that other 
sympathetic nerves may assume the function of those removed anc 
re-establish the tone of the blood vessels. 
Medicinal therapy has been the most common form of remed. 
for years. l'he use of sedatives such as bromides and barbi tur 
ates was common and is still in vogue. lhese sedatives reduce 
the nerve and muscular tension by controlling restlessness, 
anxiety, and fear. l'he patient is induced to relax and to 
sleep. Another important dr~g in use during the last twenty 
years has been potassium thiocyanate, the mode of action of 
which is still a mystery. Some other drugs have been used in 
the past but have been discarded. Some of these drugs are tra 
di tional and others need further investigation. Watermelon 
seeds, garlic, sunflower seeds, pumpkin seeds, mistletoe, Vera 
trum viride, potassium iodide, tenzyl benzoate, renal tissues, 
organ extracts, and vitamins, have all been tried,. At present, 
investigations on new drugs like tetraethyl ammonium chloride, 
veriloid, dibenamine, and others, are being conducted with en-
couraging resuJ;.ts, but much more investigation is needed to 
solve this nhypertensi ve pu z zle 11 • 
No disease in the world needs therapy more urgently than 
hypert.. ension. Results with diets and sympathectomy show that 
high blood pressure fulfills no necessary function in the orgar: ~ 
ism, since its lowering in certah1 patten ts produces no harm-
12 
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========~==~~~~==~~~~~==~~-~======~~========~======~~F=====~ ful effects but only benefi cial ones. Since sympathectomy im-
plies a major surgical operation after \'lhich reduction of bloo 
pressure cannot be fore·told and the pre-operative levels are 
sure to return, the drug tl"eatment becomes, then, a common and 
.usual treatment. In order that drugs be of therapeutic value, 
they must lower the blood pressure significantly in a great 
number of cases, cause no serious harm to t he individual and 
produce an effect for at least eight hours to avoid interfe-
rence with t he normal habits of the patient. Drugs with one 
or more of these characteristics are beingused in daily re-
search institutions, hospitals, and laboratories. HovTever, 
much remains to be done before the ideal goal is achieved. 
II. PHYSIOLOGICAL EFFECTS AND HYPOTENSIVE ACTION OF DRUGS 
· Hypotensive drugs have different modes of action. Some 
of these subtances, like the nitrite group, are capable of in-
creasing the lumina. of the arterioles by acting on the smooth 
muscles of the blood vessels; others, like 933F and plasmoch 
can cause marked vasodilation by means of nerve path1-1ays vlhere 
inhibition of the s~mpathetic reflex mechanism is produced. 
These drugs are called sympatholytic. A third group of subs-
tances, like dibenamine and tetraethyl ammonium chlroide, can 
block nerve transmission at the ganglia and are called ganglio-
nic blocking drugs. 
A. Physiological Effects .~ Hypotensive Action of S:y:mpathol;t-
tic .. Dr!lf)s. 
Sympatholytic drugs inhibit or nulli~y sympathetic vaso-
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blood vessels and usually acting at the end organ (Grimson, 
Hendrix, and Reardon 1949). 
The numerous experiments with sympatholytic drugs are 
promising, but most of the compounds tried produce aide effect 
that are undesirable and make their use as a hypotensive drug 
discouraging. Due to the great need for medicinal therapy in 
the treatment of hypertension a great number of' new drugs are 
now being investigated in laboratories. Some of' these have 
relieved the subject's symptoms sufficiently to encourage fur-
ther investigations. Among the newer sympatholytic drugs are 
priscoline, dehydroergocornine, and 933 F. Plasmochin and 
pentaquine produce transient hypotensive effects, thus are 
studied -r;i th less interest. 
1. Dehydroergocornine 
Deh;yar:cergocornine is one of the dehydrated ergot alka-
loids having the advantage that it can be administered both 
orally and parenterally. This is one of the reasons why its 
use has become .so popular. Wilkins, Freis, and Stanton (1949) 
noticed that the administration of the drug to patients caused 
postural hypotension like that produced by tetraethyl ammonium 
chloride, but differing from it in the absence of tachycardia. 
The cardiac output, measured by the Fick method, and the heart 
rate, were found not to change significantly, in contrast to 
the cardioaccelerator effects often seen after the administra-
tion of tetraethyl ammonium chloride. The pulse rate was de-
creased at the early stage of the hypotensive action but in-
creased under the stable phase of the action of the drug. He-
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patio portal flow and renal flow were noticed to decrease while 
the peripheral blood flov1 increased as measured 1vith a plethys-
mograph. Freis, Stanton, and Litter (1949) found that on the 
administration of the drug, sympatholysis was produced like 
that observed af'ter sympathectomy. They noticed an inhibition 
of the cold pressor response, decreaaed vasoconstrictor l"'es-
ponse in the fingers and toes, and a rise in skin temperature. 
The results so far obtained with this drug suggest that 
it is of sympatholytic nature. Stanton, Wilkins, and Freis 
(1949) assume that the pressure lovrering action of dehydroer-
gocornine is due to a change in the blood pressure regulating 
and integrating mechanisms in the central nervous system, re-
sulting in a readjustment of the blood pressure in the organs. 
This readjustment is produced in a way that adequate venous 
return and cardiac output are maintained. Since the heart 
rate is diminished no palpitations are produced as would be 
expected from the buffer action of the carotid and aortic re-
flex mechanisms. 
2. Hxdergine (CCK-179) 
Hydergine is a combination of the three dehydrogenated 
ergot alkaloids of the dimethyl piruvic acid group. Studies 
have demonstrated that it can be tolerated better than any of 
the other dehydrogenated ergot alkaloids alone. Like dehyd.ro-
ergocornine, the drug can be administered both orally and pa-
renterally, but a combination or the two ways gives better and 
faster results. 
Ka.ppert (1949) reports impr_ovements in high b.lood pres-
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sure and its symptoms after t he use of hydergine. Improvements 
were noticed after tw·elve days of treatment which w·ere main-
tained for twenty or thirty days. At the end of this period 
therapeutic results were obtained. There were improvements in 
renal function, headaches, vertigo, f'atigue, sleeplessness, 
t r emors, electrocardi.ograph records, and high blood pressure. 
How the drug acts to produce these effects is not thoroughly 
understood, but it is suspected that it is an action similar 
to that of dehydroergocornine, where the lower blood pressure 
is due to a readjustment of the pressure regulating mechanism 
in the central nervous system. 
3· ~ Fourneau compo~ 
Piperydil methyl benzodioxane (933F) has been investi-
gated for hypotensive action. After the administration of the 
synthetic drug the most marlted effect is a diminishing response 
to sympathetic effectors. Drill {1949) states that the drug 
acts as an adrenolytic agent when used 1n low doses, the pres-
sor ef fect of injected adrenaline is decreased e.nd then abo-
lished with increasing amo~ts of' the injected drug, producing 
as a result a decreased blood pressure. In high concentrations 
the drug acts as a sympatholytic chemical substance ab~ishing 
sympathetic nerve stimulation. In further experiments Drill 
reported that if the drug was administered to unaesthetized 
dogs by constant infusions of two minutes instead of the usua.l 
thirty seconds, side reactions such as flushing, nervousness, 
palpitations, cold, heade.ches, fright, and dizziness \fere pro-
duced, together with an increased he~rt rate which was above 
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that produced by adrenaline, central nervous system stimulati-
on, or hypertension itself. 
Ross (.1936) states that benzodioxane, as \vell as yohim-
bine, i ncreases the polarization of the membrane of the nerve 
cells making them less permeable, thus decreasing the cell res-
ponse to agents like adrenaline. This variation in cell mem-
brane permeabi lity does not affect the sympathin that is .libe-
rated intracellularly as a result of nerve stimulation, al-
though there is a decrease in the diffusion of the substance 
to t he cells, possibly because not all o:r the smooth muscle · 
cells receive a nerve supply. ~nis will result in a decreased 
response of smooth muscles {Ross 1936). 
4. Prisco11ne 
Hartman and Isler (1939) experimented \'11th a group of 
phenil-substituted alkyl imidazolines and were the first to 
note that among them, Priscol produced the greatest blood pres-
sure reduction. In the same year Meier and Hueller (1939) re-
ported that Priscol (subsequently changed to Priscoline) dila-
ted the blood vessels of the skin, mucosa, and extremities. 
They went on to prove that the drug (2-benzyl-4, 5-imidazoline 
hydrochloride) is an adrenolytic substance since dilation res-
ponses vrere obtained on injections of adrenaline and that drug 
at the same time. Further experiments conducted by Chess and 
Yonkman (1946) on adrenolytic and sympatholytic action of Pris-
col in rabbits, demonstrated a marked decrease in both systolic 
and diastolic blood pressure. The pressure reductions were so 
marked (220 over 102 to 156 over 40) that they compared the ac-
17 
tion of the drug to that observed af'ter sympathectomy. In that 
same year Chess ~~d Yonkman demonstrated that although Prisco-
line 't'ias adrenolytic it tvas not sympatholytic to all cervical 
sympathetic functions. Ahlquist, Huggins, and Woodbury (1947) 
reported that the drug acted primarily as an agent that produ-
ces peripheral vasodilation, cardiac stimulation, coronary va-
sodilation, increased cardiac output and some iruLibition of the 
muscles in tb.e ga.str-•ointestinal region. The studies on Frisco-
line, then, show that the drug is an effective sympathomimetic 
antipressor and adrenolytic agent.: Hm-rever, although encoura-
ging results have been obtained there are several tmdesirable 
side effects, including flushing of the skin, goose flesh, nau-
sea, and palpitations that are present after physiological do-
ses_. 
5. ;R_entaquine 
Loeb (1946) noticed that he could produce postural hypo-
tension in normal patients by using t he new antimalarial agent 
pentaquine, raising the question whether this dx•ug could be 
used to treat hypertension. 
!?l"eis and tofilkins (1947) observed in hypertensive men and 
dogs that the antimalarial drug [6-methoxy-8-(5 isopropyl-ami- · 
noamyl amino) quinoline] reduced both the systolic and diasto-
lic blood pressures when given orally in doses ranging from 
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120 to 240 mgm. per day. The drop of pressure was measured by 
means of arm sphygmomanometers and was detected. at the end of 
two to seven days of treatment. It developed abruptly, recedin ~ 
gradually aver a period of several davs to several weeks. a.s 
the administration of the drug ceased. A difference in the 
response of patients to the drug was detected between t hose 
with essential and those with malignant hypertension. The sub-
jects with malignant hypertension responded to a lesser dosage 
than t hose ~1ith essential high blood pressure, although no im-
provement in t he renal functioning was noticed. The pulse rate 
remained unchanged but t he hypotensive effects were preceded by 
abdominal, back at.""ld chest pains of girdle character, nausea, 
vomiting , anoxia, pallor of the face, constipation, diarrhea, 
impotence, and in some cases loss of weight. 
It has been suggested that the hypotensive action of the 
drug is due to its toxic activity since toxic symptoms were 
produced so frequently. This idea was discarded when no corre-
lation could be found between the appearance of toxic symptoms 
and hypotensive effects, since the hypotensive action of the 
drug was still present several days after the disappearance of 
toxic symptoms (Freis and Wilkins 1947}. This may suggest 
that at therapeutic doses the toxicity and hypotensive quali-
ties of the drug may be separated. 
Preliminary studies in the mode of action of the drug 
show that it is sympa~~olytic. Since the pulse rate is not ac-
celerated and the heart rate is maintained v1ithin normal range, 
suggestions have been made as to a probable depressor effect 
involving the cardioaccelerator mechanism. Recordings of arte-
riolar blood pressure using Hamilton manometers and recordings 
of cardiac output by means of a ballistocardiograph indicate 
that there is a reduction of sympathetic vasopressor reflexes 
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when pentaquine is used, similar to the effect of sympathecto-
my ( ~vilkins, Culberston, 1949). These findings were confirmed 
by Mixter and Freis (1949) by measurements in skin temperatures 
of the extremities, which indicated a depression of sympathetic 
activity. Since blood vessels responded to inj~cted epine-
phrine, no block was produced. 
The toxic effects of the drug at normal physiological 
doses have been too frequent and too severe to assure hypoten-
sive use of the chemical substance. 
6. Yohimbine 
Of all the drugs tested as possible hypotensive chemical 
substances, yohimbine (quebrachine) has been investigated the 
least. According to Cushny's Fhar.macology and Therapeutics 
(1947), this alkaloid can dilate the blood vessels of the skin 
and genital organs even when present in very small doses. This 
dilation causes a sensation of warillth and erection of the geni-
tal organs, thus promoting sexual desire. 
The mode of action of this drug is similar to the action 
or benzodioxane, where an increase of the polarization or the 
cell membrane makes the cells less pe~~eable to adrenaline, de-
creasing the response of the cells to this agent or to an adre-
naline-like substance.;' 
Yohimbine, like the other five drugs discussed in the 
above sections are called sympatholytic because in one way or 
another they prevent or inhibit the action of the sympathetic 
system upon the blood vessels. This action apparently takes 
place at the terminal end in smooth muscles. Some of the drugs 
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may act by preventing the action of the mediator on the res-
ponsive system, like Priscoline. Others prevent the access 
of the stimulant mediator to the responsive system, while 
others can have more than one characteristic action, like 
933 F. 
B-:. Physiological Effects ~ Hyp~tensive Action of Garu.\lion1c 
Blocking Drugs 
There are certain drugs that do not prevent the action 
of the mediator at the end organ but instead block the con-
duction of the nerve impulse at the ganglia. These substan-
ces have been classified as ganglionic blocking agents. Among 
the new ganglionic blocking chemical substances the most im-
portant are: 
1. Etamon 
The paralyzing action of the quarternary salt of ammonia 
tetraethyl ammonium chloride (Etamon) was recognized as far 
back as 1915 by Burn and Dale, and was later studied by Hunt 
in 1926. They suggested that a substance like Etamon, ·which 
could paralyze ganglionic cells would be of great therapeutic 
value in the treatment of hypertension. No attempts were made 
then to use it as a tool. The interest in these drugs has 
been revived recently and studies are being conducted to test 
their hypotensive effects on patients as well as on laboratory 
animals. 
Freis (1948) administered Etamon (Parke and Davis) to 
dogs and foWld that it \va.s effective only when given paren-
terally. He also found that on the administration of .2-.3 gm 
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tachycardia, increased pulse r a te and palpitations were pro-
duced together with some paralysis. of visual accommodation and 
alteration of urinary bladder functioning. fhe effects on 
blood pressure were confirmed by Fass and Doupe (1949) who 
observed marked vasodilation after the intravenous administra-
tion of the drug. 
The ganglionic site of the action of :.r. E. A. was estab-
li::;hed by Acheson and coworkers (1946) . in the frog. 1'etra-
ethyl ammonium chloride prevented the action of preg~glionic 
stimulation of the stellate and sympathetic cervic al ganglia 
on the nictitating membrane of the frog while postgcnglionic 
s t imula tlon remained effective. It was later shovvn by Chow 
and deElio (1947) that the response of the nictitating membranE 
of the frog to an injection of acetylcholine into the peripher 
al cervical gangli a was reduced or abolished when f. E. A. was 
present. Moe (1948) showed tha t the drug erases the post-
. 
ganglionic action potential aroused by the preganglionic s tim-
ulation of the stellate ganglia in the dog. Acheson and 
Pereira (1946) proved that parasympathetic as well a s sympa-
the tic ganglia are inhibited by tetraethyl ammonium chloride, 
although the proof sometimes is indirect because of the anatom-
ical distribution of parasympathetic ganglion cells. ·rhe site 
of action must be the ganglionic synapse since tetraethyl ammonf-
ium chloride blocks the cardiac action of vagal stimulation but 
not of acetylcholine. In 1949 Heyman reported that the site 
of mediation could be classified in terms of the action of 
acetylcholine on gangl-ionic cells 7 smooth muscles and striatec 
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muscles cel ls. ·rhis cla ssifica tion is supported by the more 
or les s antagonistic action of acetylcholine at the three 
sites. Why it is that atropine blocks "muscarine ac t ion", 
curare block s neuromuscula r and ganglionic tr cw.'lsmission in a 
lesser degree is not knovm. Vfuy i t i s tha t tetra ethyl an@oni -
um chloride block s the gangli a has been and still is a puzzlinr 
question. If the theory is adopted that acetylcholine reacts 
with three closely related but different substances at the 
three sites of action and tha t the three sub s tances comp ete 
with acetylcholine for the receptor, then i t can be said that 
the drug I . E. A. 11 fi ts 11 with the ganglionic recep tors and 
inu scarine 11 fi ts 11 with musc arine recep tors (Hunt and Renshaw 
1933; Heymans and Gvandeses 1949). 
Loren te deNo (1949), while studying the qu arternary salt 
of ammonia containing at lea st three ethyl groups, noticed tha i 
·these salts, as well as I. E. A., were capable of res to ring 
some degree of excitability to axons soal{ed in a sodium-free 
medium. These salts are also capabl·e of inhibiting some gang-
lionic t ransmission. Ihe blocking action of r. E. A. wa s then 
related to its effect upon axons, but no quantita tive compari-
son between axons and drug has been ma de. 'l'here is no exp eri-
mental evidence that both phenomena are related. It is said 
that the probable action of the substance in ganglionic block-
ing is of a competitive nature. Lorente deNo succeeded in 194£ 
in reversing the gnnglionic block by the use of neostigmine. 
This substance has been used as antidote for the toxic effects 
of tetraethyl ammonium chloride. 
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Coller (1939) showed that the drug had no effect on the 
blood flow in sympathectomized extremities of dogs. In the 
same year Page experimented with anesthetized dogs by giving 
them a dose of 5 to 10 mgm. of . f. E. A. He found that the 
response created by the drug was inconstant with pressor and 
depressor actions. Ihe depressor response was abolished by 
subjecting the animal to lumbodorsal sympathectomy. As a re-
sult of this experiment Page concluded that there are several 
factors responsible for the changes of blood pressure. He 
listed them as autonomic blockade, liberation of a pressor 
substance from the liver, and liberation of adrenaline from 
the adrenal glands. 
Further experiments have shovn1 that the drug f . E. A. 
blocks transmission through the autonomic ganglia, decre&sing 
the blood pressure and increasing blood flow. 
2. Dibenamine 
The substance N, N-dibenzyl beta-chloroethyl amine hydro-
chloride, commonly called dibenamine, occasionally produces 
toxic effects and states of confusion which are di scouragi..n.g 
from the standpoint of the treatment of hypertension. However, 
it has been used as a potential substitute for regional sympa-
thetic block or actual sympathectomy in p eripheral circulatory 
diseases. 
One of the mail1 disadvantages of this drug is its caustic 
nature, since it is a derivative of a nitrogen mustard and can 
not be given in any way but intravenously in very dilute solu-
tions by a constant dripping infusion for the period of one hour-. 
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Haimovici and coworkers (1948) experimented giving oral ad-
ministrations to rats. Dosages used were 111 mg. per kg. A 
reduction of blood pressure was noticed in both normal and hy-
perta.YJ.sive animals. This fall of blood pressure was usually 
greater ru1.d more prolonged in animals having high blood pressurG. 
In spite of the drawbacks of the drug it has the advantage of 
producing hypotension which may persist from several hours to 
several days. 
Grimson, Keith, Hendrix, and Reardon (1949) found in 
clinical treatments. that the action of dibenamine was adreno-
lytic and sympatholytic, causing in sufficient doses a gangli-
onic block and vasodilation. 
3. sc ~ 
There is a new autonomic ganglionic blocking drug that 
is being studied at pres:ent by Cook, Donald, Hambourger, and 
Bianchi (1950). This drug is 2, 6-dimethyl-l, 1-diethyl pi-
peridinium bromide, commonly called SC 1950. Cook a~d co-
workers obtained a blocking action after the administration of 
the drug. In experiments on cats under pen to barbital anes the-
sia, the nictitating membrane was kept under sustained contrac-
tion by stimulation of the craYJ.ial end of the seared vagus 
nerve. fhe continued contraction was temporarily relaxed by 
tetraethyl ammonium chloride and SC 1950. Since it has been 
proved (Acheson and coworkers 1946) that T. E;. A. is a sympa-
thetic ganglionic blocking agent acting upon the cervical sym-
pathetic ganglia, it is assumed that SC 1950 has a similar mode 
of action. The bloclc was in the sympathetic cervical gan-
-glion because the injection of epinephrine through the vein 
produced a second full contraction during the relaxation pe-
riod caused by T. E. A. and SC 1950. Consequently SO 1950, 
like T. E. A., does not abolish or diminish epinephrine pres-
sor responses. In ita blocking effects this ne\'l' drug is 
thought to be about seven times more potent than tetraethyl 
aw~onium chloride, causing a reduction in blood pressure as 
low as 86 to 90 mm. of mercury with doses as small as.25 mgm. 
over kilogram. 
4. Phenol ~ Pentam.ethonium iodide 
Phenol and pentamethonium iodide are of minor impor-
tance in the treatment of hypertension and will be briefly 
discussed. 
Haxton (1949) reported that he had been able to produce 
non-operative interruption of sympathetic activity by the use 
or paravertebral injections of a 10 percent aqueous solution 
of phenol. He suspected that the action of phenol was one of 
destruction of the ganglionic cells, preventing nervous con-
duction. 
The action of penta.methonium. iodide was studied by 
Arnold, Goetz, and Rosenhein (1949). ~larked vasodilation was 
observed, similar to that produced by tetraethyl ammonium 
chloride, as measured by means of digital plethysmographs. 
The dilation began one minute after the parenteral adminis-
tration o£ the drug and lasted for one hour. The mode of ac-
tion, according to Arnold and coworkers, is upon the paraver-
tebral sympathetic ganglia where a block is produced, prevent-
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ing nerve conduction. 
C. PHYSIOLOGICAL EFFECTS AND HYPOTENSIVE ACTION OF DRUGS THAT 
- . . . - -.-.-
!QI .-.PER=· I=P=HERAL=· =- ;.:::Y 
Under this heading are classified those drugs which re-
lieve hypertension by acting upon the amooth muscles of the 
blood vessels or by causing a reduction of blood pressure by a 
reflex mechanism originating in the smooth muscles of .the blooc 
vessels. Also included are some drugs of undetermined action 
but of suspected peripheral effect. 
1. Veratrum drugs 
Veratrum drugs have been used since the latter part of 
the nineteenth century in the treatment of pneumonia, fever, 
and eclampsia, because of the decrease in heart rate and car-
diac activity following administration. The effect of Vera-
trum viride "'as described as early as 1874 by Wood and in 1914 
by Havetain. The classic opinion has attributed the decreased 
blood pressure to cardiac depression through the vagus nerve, 
althou~~ in 1925 McNider could not explain this fall of blood 
pressure by vagus reflex lowering of the heart rata, after he 
administered an injection of tinctw."e of Veratrum viride in 
experimental hypertension created by means of epinephrine in-
jections in vagotomized dogs • 
.In the early experiments the drug was administered in 
alcoholic extracts, pulverized rhizomes, or whole dry plant 
preparations. Since no assay was possible the evaluation and 
results obtained \'lith t h e extracts or whole dry plant prepara-
tions w·ere not theraueutically satisf'actor:v. It was tho'Wl.ht 
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that the drug should be administered until the pulse returned 
from high levels to normal. This ofta~ produced an abrupt 
lowering of blood pressure and heart r a te that wa s dang erous 
to the patient. Since Veratrum viride is a combina tion of 
several chemical substances the estimation of its potency was 
difficult to make, lending an atmosphere of mystery to its use. 
Because of the extreme toxicity of l arge doses of the drug its 
use became less frequent, except in the treatment of eclampsia. 
McNider noticed that if the pulse r a te was kept at or below 60 
beats per minute, the patient did not have convulsions. Thus 
the pulse rate was used as an index of the amount to be adminis 
tered. The chemical structure of Verqtrum drugs has been clari l 
fied recently. The fact that its chemical substances resemble 
the cardiac glycosides has contributed to their popularity. 
The term nvera trum alkaloids" refer to all alkaloids faun ,i 
in Veratrum species. The term veratrum refers to the galenical 
preparations of certain species of veratrum. 'l'he two most com-
mon species are Veratrum viride (Aiton) common to North Junerica 
and Veratrum album (Li~~), native of North Europe. Many chemi-
cal substances are included under the name Veratrum vi ride or 
Veratrum album. Most of these have been isolated and crystal-
lized in pure form and tried in hyperta~sion. Krayer (1950) 
has tabulated t welve different veratrum extracts. Some of thes 
are secondary amine bases, some are ester alkaloids, and others 
are products of hydrolizatioh. The ester alkaloids are more 
powerful than the alkamines, which in turn differ in toxicity 
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TABLE I 
CHEMICAL FORJ.\flJLAE AND CONSTITUTION OF THE VERATRtm DRUGS AS 
EXPLAINED BY KRAYER IN "UNTERSUCHUNGEN UBER DIE KREISLAUF-
\i!RKUNG DU VERATRI~UUW[ALOIDE 
Archiv. fur Experimentelle Pathologie 
und Pharmacologia. April 1950 
------------------------- ~---------------------------------
Name of Drug Formula Constitution 
-----------------------------------------------------------
Germerine Alkaloid 
Veratridine C36 H51 o11 N Alkaloid 
-----------------------------------------------------------Cevadine C32 H49 09 N Alkaloid 
-----------------------------------------------------------Pseudojervine C33 H49 08 N Amine 
-----------------------------------------------------------Veratrosine c33 H49 Or N Amine 
-----------------------------------------------------------Veratram1ne Amine 
-----------------------------------------------------------Jervine c27 H39 o3 N Amine 
------------------------------------------------------------Germine c27 H43 08 N Alkaloid 
-----------------------------------------------------------Protoverine c27 H43 o9 N Amine 
-----------------------------------------------------------Protoveratridine Alkaloid · 
-----------------------------------------------------------
DRUGS THAT CAN BE HYDROLYZED 
Protoveratrine + 3 ~0 
---
Protoverine 









Germer1ne +-3 H20 -----.;;.. Protoveratridine 
Protovaratr1d1ne +-3 H20 ~ Germine 
among themselves. Ihe toxicity of the alkaloids depends on the 
position and number of acetyl groups in the molecule. 
Veratrum viride as a drug i s given in doses of 10 Cro.w 
units per hour. A Craw unit is the amount of the drug needed 
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to cause a reduction of heart rate in the Daphnia magna. Ihe 
effects of the whole drug are noticed after 1 to 2 hours of its 
administration, becoming maximum from 4 to 6 hours, and dis-
appearing at the end of 14 hours. Some side effects are noticE:i, 
such as salivation, nausea, and vomiting. Fr·eis (1949) and 
Stanton and Moister (1950) made a systematic assay of various 
fractions of Veratrum viride and revealed that the hypotensive 
effects of the crude d1~gs were due to the presence of certain 
ester alkaloids. Of these they separated two:, germi trine and 
germidine. lhe veratrum alkaloids as a group have specific 
physiological action. Ihe group can. cause abnorrnali ties in 
the rate of respiration, the hear t rate, and in nerve conduc-
tion (Krayer 1946). Krayer believed that all the ester alka-
loids can decrease the res) iratory rate of mammals whether under 
anesthesia or under normal conditions, although the minimal 
dose that can cau se a decreased respiratory r a te is much higher 
than. the minimal dose influencing the circulatory sy s ter11. 
Cr.s.mer (1915) noticed respiratory changes after the use of the 
drug. He explained these change s as partly due to respiratory 
reflex action and partly due to central nervous action. E;x-
periments on cats and rabbits conducted by J arisch and Richter 
(1939) demonstra ted that the circulatory response to the drug 
was not abolished by excluding the depressor nerves, but the 
respiratory action was prevented by cutting the vagi. Ihis 
experiment suggested that the receptor areas for the inhibitory 
respiratory reflex are in area s supplied by the vagi and prob-
ably located in the chest region. Ihe exact site of action of 
the veratrum alkaloids responsible for the decreased respira -
tory rate has not been exactly pl c-J. ced. l'here i s no evidence 
concerning the rel c:, t i ve importm1ce of muscles, di aphra.gm, or 
their nerves in the respiratory inhibition. 
Veratrum alkaloids affect th e circul a tory system of mam-
mals. For :a1any years the dru g has b een considered as a c a rdiac 
.depressant acting through ve.gal stimula tion. l'he discrepancy 
in the literature concerning reflex as opposed to central fac-
tors involved in heart rate decrease has now been solved. Vaso 
dilation contributes to the fall of blood pressure. It is sus-
pected to be the primary action of the drug in eclampsia. On 
administration of ·small doses of the drug there is a transient 
decrease of blood pressure. 1he decreased pressure is produced 
also by the administration of the pure alkaloids, being direct-
ly proportional v1ith the dosage administered. Wilson and Smith 
(1943) working with animals found tha t the crude drug increased 
the perfusion r c.te in certain organs, caused a lowering of bloo 
pressure, increa sed the size of leg volume, but pro duc ed no 
chan ges i n t h e respi ra tory r a t e or r hy thm of t he h eart. In the 
year 1 915 Crc:rner repor t ed tha t althou gh some c a rdiac slowing 
wa s p ro duced by the us e of Vera t rum viri de, t he decreased blood 
pressure in t he gu t wa s prirrtarily due to v agal reflex vasodila- J 
tion. He also observed ail incr_e_ase in intesti n aJ as wPll Rs 
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ki<LYJ.ey volume. VIi th the peripheral circulation excluded large 
doses had no effect on the cardi ac action af.ter vagotomy, ruling 
out a direct depressor action of the drug u pon the heart. Wil-
kins (1949) reported that the cardiac output, as measured by 
the Fick method, did not decrease after the administration of 
the drug, consequently lowering of the blood pressure had to 
be due to decreased peripheral resis tance. Since blood flow 
varies directly with blood pressure and inversely v:i th p eri-
. pheral resistance, :an increased flow should be expected if the 
peripheral resistance is decreased. Su ch is the case . 
Jarisch and Rlchter (1939) demonstrated that the most im-
portant area for the reflex mechm~ism responsible for the hypo-
tension produced by the drug is the heart itself, but since 
Cramer h a s found effective ar~as in the lung s, other sites 
could be involved. Krayer (1946) found that the greatest 
reflex reduction of blood pressure or·igin<:l.ted in the a rea su p-
plied by the left circumflex and left anterior d. e~. cending cor-
onary artery . He could find effective areas in the lungs by 
perfusion of the drug in lung preparations, but thEse areas 
were about ten times less sensitive than the left ventricular 
area . Freis and Stan ton (1949) showed that the drug stimula-
ted the afferent v agi nerves in the thorax,. myocardium, and 
left ventricle. lhe nerve discharge traveled to nerve centers 
in the brain and these initi a ted a reflex f all in blood pressurE . 
The h E-art r a te was somev;h a t increased as the result of the 
reflex mechanism origina ting in the chest region. l'his reflex 
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is called the Bezold effect in honor of A. von Bezold, who in 
1867 observed the dilating action of veratrine and described 
its effects in such a mechanism. 
When used in high concentra tions the Veratrum viride al-
kaloids act as vasoconstrictors by a direct effect on the wall~ 
of blood vessels or the adrenal glands, causing a discharge of 
epinephrine, which in turn acts indirectly as a constrictor 
(Krayer 1946). 
fhe most importa11t chemical substances found in veratrum 
drugs are as follows: 
a. Veratrine 
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Veratrine was studied by Rosenblueth and del Pozo (19LJe) 
in cats under dial anesthesia (Ciba 0.7 cc per kgm. intraperi-
toneally). :Ihey recorded the con tr actions of the nic ti ta ting 
membrane and electrical responses proximad and distad to the 
cervical sympathetic ganglion. When veratrine was injected 
intravenously, conduction across the ganglion decreased 10 to 
20 percent. Large concentrations of the drug produced blocking 
actions since stimulation of postganglionic fibers often f ailed 
to evoke a response. 
Veratrine resembles aconitine in general characteris-
tics and particularly in regard to the effect on sensory ending;,. 
Whan toxic doses are given, coughing and sneezing result from 
conta ct of small quantities of the drug with the mucose of the 
nose a11d thro a t. After the irrita tion the sensory endings 
in the skin become less sensitive a11d a sen:sation of cold is 
noticed, (Grollman and Slaughter 1947). the most char acteris-
tic action of the drug is upon the . str±ated muscles. Szent-
Gyorgyi (1939) noted an awkwardness in the movemen ts of frogs 
after injection of small amounts of the drug in to the dorsal 
lymph sac. He exposed an excised muscle to a solution of the 
drug vihile recording the response t o electrical stimula tion, 
no tieing that the height of the contraction was incr·eased and 
the relaxation period prolonged 80 to 30 times over the normal. 
0 ther effects of the drug are strong and prolonged ven-
tricular systole, maintenance of noraml auricular rhythm, slow-
ing of contractions, and finally cessation of the heart. 
b. Veratridine 
Veratridine is an amorphous alkaloid ester of the al-
kaloid cervine with one molecule of veratric acid. It is one 
of the veratrine alkaloids which have not yet been found in a 
crystalline .state in ·Veratrum v~ride or Veratrum album. Its 
effects upon the blood pressure are similar to those caused 
by v-eratrine. 
c. Veratramine 
While experimanting .with heart-lung preparations in 
dogs, Krayer (1950) found that the drug has antiaccelerator 
action on the pacemaker of the heart. 
d. Protoveratrine 
fhis drug is obtained from Veratrum album. It is a 
crystalline ester alkaloid of the alkamine protoverine and the 
three acids: acetic, methyl-ethyl acetic, and methyl-ethyl 
=====#===Ei'""-;:~.1-~v..~d:l~'oJ.; ,.. T t. i c: ,..,n e a f the mo s t imJ:w r tan t alkaloids of Vera-
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trum album and has not yet been found in Veratrum vi ride (Meil-
man and Krayer 1950). It is the most poisonous of all the alkar-
loids found in Veratrum album. 
e. Veriloid 
This drug has been described by Stutzman, Mai son, and 
Kusserow (1949) as a mixture of alkaloids from Veratrum viride, 
probably of amorphous substances. It is knO\m that this new 
drug exerts a profound hypotensive influence by dilation of 
the splanchnic, skin and skeletal mode arterioles. This dila-
tion is not influenced by atropine or related drugs. 
Veriloid is the only Veratrum viride deriva.tive that 
is biologically standardized in mammals , since a drop in blood 
pressure in dogs is used as end point. fhe results are then 
directly transferable to humans making for absolute uniformity 
and pharmacological potency and hence uniformity of thera.peu tic 
effects. I'he main purpose of this drug is to relieve the high 
blood pressure in order to reduc e the cardiac burden and 
minimi ze the danger of vascular ac cidents. This reduced point 
does not have to be necessarily a lovvering of blood pressure 
into the ordinarily considered normal levels, since in patient:: 
with long standing hypertension a marked drop of blood pressure 
to normal may be undesirable because the patien t 1 s vascular 
system has been conditioned to a high pressure for a long 
period of time. The blood vessels may not be capable of ad-
justment to low pressure because of certain organic changes 
of pei'!llanent na ture in the arter io l:ar wal ls (Stutzman and Maiscn 
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1950). 
A desirable feature of Veriloid is its failure to inter-
fere with the normal variations of blood pressure that occur 
in emotional tensions. lhe patient is not prevented from the 
vasomotor lability which normally comes in to play during perio 
of great emotional tension, since even in the case of a signi-
ficant reduction of blood pressure, transient blood. pressure 
rises cen take place coincidental with emotional reactions lik 
fear, apprehension, anger , and rage (Wilkins, Stanton, and Fre 
1949). Another desirable effect of the drug is that it can be 
administered both parenterally and orally. If the drug is tak 
in excess, overdosages are readily detected, since toxic symp-
toms a ct as pro tee ti ve mechanisms and their appearance is ben 
ficial in calculating the correct doses to be administered. 
Some of the toxic symptoms are high esophageal burning, epi-
gastric heart burn, nausea and vomiting. 
In studies done at the Boston University Graduate Schoo 
by Janek and Asensio in the hamster and frog respectively, it 
was noted that the use of toxic doses of the drug, applied 
topically to the pouch preparation in the hamster and retro-
lingual preparation in the frog, caused constriction of the 
arteriolar bed resembling in action that of veratrine and ver 
tridine and other veratrum alkaloids as reported by Krayer . 
l'he heart rate was found to lower, suggesting a po ssible cardi 
inhibition through vagal stimulation. As the drug administer 
was decrec.,sed from toxic doses to physiological doses, there 
35 
greater at physiological doses. 
Stearns (1950) and Stutzman, Maison, and Kusserow (1949) 
explained that the effects o-f Veriloid can be intensified by 
the use of phenobarbital and related drugs, especially if ex-
cessive emotional tension is an etiologic factor. Because of 
the slight cardiac slowing effect of Veriloid, digitalis can 
be administered in con~unction with the drug and in very small 
doses. Ihey found tha t th~ . only drug whose use is contra-
indicated to. Veroloid therapy is Quinidine. 
2 . Nitrites 
Nitrites are chemi cal substances tha t reduce the high 
blood pressure by direc t action on the smooth mu scles of the 
blood ve ssels . fhis substance makes the smooth muscles dilate 
and relax a few minutes after its administra tion and for a peri 
od not longer than one hour . I t is used when r apid therapy is 
needed without side effects (Her ndon cmd lhomas 1946) . 
3 . Potassium thiocyana te 
There is a difference in opinion regarding the va l u e of 
po t assium t hiocyan a te in hypertension . r his discrep ancy is 
probably due to the narrow ma.r gin between the clinical and 
toxic doses of t he drug. In 1936 .i'v.l.ar b: er showed that toxi ci ty 
and therapeutic activity are related to the blood concentration 
of the dru g . He demonstra t ed that the Qu antity of the drug ad-
mini s tered should be based on serum es tima tions and not on 
blood pre s su re mea surements , thu s controll ing the danger of 
overdoses. Al though the symp toma tic relief and blood pressure 
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c ases t h e con tinued admini stra tion o f the dru g doe s n ot p r event 
t h e progress of the disea s e ( Vla t k i nson an.d Ev <:ill s 1947) . 
l'h e drug is thought t o h ave a slight ci epres sant a ction 
on the c en tral nervous system but its cl a ssic toxic effect is 
one of relaxa.t ion, implying arteriolar vasodil a tion. l"h a t t his 
is the mode of a ction in non- toxi c doses has not yet been esta b-
li shed. There are suggestions t h a t i t may act by a reducti on I 
of the basal metabolic r a te (Goldri ng and Ch a sis 1932 ; Barker 
I I I. CONCLUSIONS 
Hypertension has pro bably a l way s exi s ted, but in r e cent 
years Army and Navy exrunin ations have r ev ealed a l a r ge number 
of men suffering from hi gh blood pressure . I he problem i s one 
of grea t social and economic impor tance, since few have reali z e 
t h a t findin g of high blood pressu re in a person decrea ses his 
chances of empl oyment and insuranc e . It is a dis £a se common in 
our populo tion and one which is n o t usually t r eated until i ts 
symptoms a re severe. 
'I'his pap er poin ts out that al thou gh the disease has no 
cure, much can be done in the way o f t herapy to rel ieve most 
of the disturbing symp t oms and help the individual to carry on 
a somewhat "normal " life. :I"he f a c t tha t hyp ertension is now 
recognized as pro bably the most important singl e cause o f dis-




Research in the true sense, done by trained investigators 
in well equipped institutions, is needed. 
IV. ABSfRACT OF fHE PAPER 
Hypertension is a disease having a high dea:th incidence. 
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Hypertensive conditions have been cl a ssified as symptomatic, 
essential and renal. 
S~aptomatic hypertension includes psychological high bloo ~ 
pressure due to emotional disturbances, cerebral hypertension, 
cardiovascular, and endocrinal hypertension due to abnormal 
functioning of pituitary and adrenal glands . 
Renal hypertension is due to a hemodynamic disturbance 
in the kidneys which decreases the blood flow, damages the 
tubular apparatus and r eleases renin into the blood stream. 
Renin activates a pl a sma globulin producing angiotonin -~vhich 
is vasoconstrictor aJ."ld increases the blood pressure . 
Essentia.l hypertension is the most common typ e of hieh 
blood pressure and the type which can be treated vvi th sympa tho-
lytic drugs . fhere is no app arent organic cause for the diseas~ 
but it ca.n be influenced by environment, sex, age, r ace, hered-
ity and diet, conditions vvhere the p eripheral resistance to the 
blood flow is increased resulting i n high blood pressure. Esse: , -
tial hypertension is treated by sympathectomy and the use of 
drugs. 
High blood pressure fulfills n o n ecessary function in t he 
org2nism. Since its lowering in pa. tien ts pl"oduc es beneficial 
effects r a ther than harmful on es, th e use of drugs is emphasize • 
----~--------------------------------.... ~ ..... 
Ihe different drugs used to treat hypertension are classified 
as sympatholytic, ganglionic blocking and those acting peri-
pherally. The classification is based on their most character-
istic mode of action. 
Sympatholytic drugs act a t the end organ and preven t 
sympathetic nervous transmission, causing relaxation of the 
arterial es by decreasing their tonus. Dehydro ergocor-nine and 
hydergine are ergot alkaloids which act upon the bl ood pressure 
regulating mechanism in the central nervous system resulting 
in a reduced blood pressure in the organs. Hydergine is toler-
ated better than dehydroergooornine. Benzodioxane and yohimbin ~ 
make the cell membrane less permeable to adrenaline or adrena-
line-like substances. Priscoline is a sympathomimetic anti-
pressor and adrenolytic agent, while plasmochin is a cardiac 
and sympathetic depressor. All these drugs cause such symptoms 
as headaches, nausea, and vomiting vfhen used in large concen tra 
tions. 
Ganglionic blocking drugs prevent the conduction of nerve 
illipulses by blockinr; them a t the ganglia . Etamon and SC lG50 . 
block the cervical SJ'lllpathetic; dibenamine is supposed to be 
adrenolytic ru1d sympatholytic in small doses, 21d g8nglionic 
blocking in high concentra tions; phenol destroys the ganglion 
cells and pentomethonium iodide .block the paravertebral ganglia 
fhese drugs also cause side effects as vomiting and irritation 
when given in toxic cases. 
Other drugs relieve hypertension by a reflex mechanism 
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originating in the smooth muscles of the arterioles. Some of 
these . drugs are veratrum alkaloids, nitrites and thiocyana tes. 
Of all these drugs the v eratrum derivatives are the most im-
portant . Ver·atrum drugs decrease the respiratory rate and in-
crease the cardiac activity by a reflex mechanism which origin-
ates in the area supplied by the lef:t circumflex and left an-
terior descending coronary artery. I'he vera trum al kaloids are 
· more th3Il one, each one having its ovm characteristics. Vera-
trine and vera tridine increase ventricular systole and decrease 
conduction aero ss ganglia . Vera tramine has an tiaccelera tor a c tipn 
on the pacemaker of the heart. · Protovera trine is the most 
poisonous of all the alkaloids of Veratrum album, and Veriloid .. 
whi ch is the only drug standardized in nw.mrnals causes epigastric 
and esophageal burning sensations, nausea, vomiting and head-
aches v.rhen t aken in toxic dose s. 
Of all the drugs discussed Veriloid is the one with more 
possibilities as a potential hypotensive chemical substcnce 
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